CNR Institutional Research Information System

STURIALE, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.782
NA - Nord America 929
EU - Europa 564
SA - Sud America 326
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 893
SG - Singapore 748
CN - Cina 394
BR - Brasile 272
VN - Vietnam 211
IT - Italia 206
HK - Hong Kong 175
FR - Francia 122
KR - Corea 68
NL - Olanda 67
DE - Germania 40
JP - Giappone 40
FI - Finlandia 36
GB - Regno Unito 31
IN - India 31
BD - Bangladesh 28
AR - Argentina 24
ZA - Sudafrica 20
CA - Canada 12
ID - Indonesia 12
MX - Messico 12
CO - Colombia 8
PL - Polonia 8
TR - Turchia 8
EC - Ecuador 7
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
TH - Thailandia 7
PE - Perù 6
SE - Svezia 6
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
AT - Austria 4
DZ - Algeria 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
UA - Ucraina 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.643
Salva come PNG Salva come JPEG
Città #
Santa Clara 443
Singapore 404
Hong Kong 174
Hefei 155
San Jose 120
Lauterbourg 84
Ho Chi Minh City 72
Beijing 71
Seoul 68
Hanoi 65
Cavallino 62
Ashburn 42
Afragola 30
Tokyo 28
Los Angeles 26
São Paulo 24
Helsinki 23
Frankfurt am Main 17
Guangzhou 17
Dallas 16
Da Nang 13
Lappeenranta 13
Council Bluffs 12
Buffalo 11
Milan 11
Rome 11
Falkenstein 10
New York 10
Rio de Janeiro 10
Naples 9
Aci Catena 8
Amsterdam 8
Brasília 8
Catania 8
Düsseldorf 8
Hải Dương 8
Johannesburg 8
Minamishinagawa 8
Santo André 8
Bangkok 7
Brooklyn 7
Haiphong 7
Orem 7
Hyderabad 6
Portsmouth 6
Belo Horizonte 5
Bengaluru 5
Bexley 5
Campinas 5
Cape Town 5
Porto Alegre 5
Ribeirão Preto 5
Araraquara 4
Biên Hòa 4
Bắc Giang 4
Denver 4
Dhaka 4
Elk Grove Village 4
Jakarta 4
London 4
Ninh Bình 4
Potenza 4
Seattle 4
Thái Nguyên 4
Toronto 4
Wroclaw 4
Abidjan 3
Charlotte 3
Dublin 3
Fortaleza 3
Guayaquil 3
Isidro Casanova 3
Istanbul 3
Kingston 3
Kuala Selangor 3
Lima 3
Manila 3
Mascalucia 3
Montreal 3
New Delhi 3
Oklahoma City 3
Osaka 3
Pouso Alegre 3
Prague 3
Quito 3
Rio Verde 3
Santiago 3
Shanghai 3
Stockholm 3
Tashkent 3
Thái Bình 3
Ahome 2
Alexandria 2
Asunción 2
Baghdad 2
Bitonto 2
Blumenau 2
Bologna 2
Boston 2
Budapest 2
Totale 2.347
Salva come PNG Salva come JPEG
Nome #
Tear N-glycomics in vernal and atopic keratoconjunctivitis 92
Caratterizzazione strutturale di polisaccaridi mediante spettrometria di massa 88
SLC37A4-CDG: Second patient 77
Advances in Purification Methods of Serum Glycoproteins for MALDI-MS Analysis of N- Glycome in Patients with Glycosylation Disorders 76
An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. 74
Phenotypic and genetic spectrum of ATP6V1A encephalopathy: a disorder of lysosomal homeostasis 74
The cerebrospinal fluid (CSF) N-glycome as a novel biomarker of Parkinson's disease. A mass spectrometry-based CSF n-glycosylation study of patients affected by Parkinson's disease 71
N-Glycomics of Human Erythrocytes 68
HILIC-MS based glycomics in the diagnosis of Congenital Disorders of Glycosylation 64
CSF N-Glycomics Using MALDI MS Techniques 63
Analisi del Glicoma del Siero di Pazienti Affetti da Disordini Congeniti della Glicosilazione (CDG) e da Galattosemia 63
HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases 63
Clinical, molecular and glycophenotype insights in SLC39A8-CDG 62
Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption 61
PROTEOMIC ANALYSIS OF HUMAN TEAR FLUIDS USING LC-MALDI MS AND MS/MS 59
Lipopolysaccharide from Gut‐Associated Lymphoid‐Tissue‐Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A 59
Aberrant sialylation in a patient with a HNF1 alpha variant and liver adenomatosis 58
Higher frequency of TMEM199-CDG in the southern mediterranean area is associated with c.92G>C (p.Arg31Pro) mutation 57
COG6-CDG: Novel variants and novel malformation 57
Messa a punto di metodi di analisi mediante MALDI TOF ad alta risoluzione sui campioni polisaccaridici IDN 5505 e IDN 5406 frazionati mediante gpc: determinazione dei pesi molecolari; analisi strutturale di due frazioni mediante metodi classici e di spett 56
CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer’s Disease 56
Secondary disorders of glycosylation in inborn errors of fructose metabolism 54
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking 53
MALDI-MS CEREBROSPINAL FLUID (CSF) N-GLYCAN PROFILES IN NEURODEGENERATIVE DISEASES 51
N-acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function 50
SLC35A2-CDG: Novel variant and review 50
Studi di stabilità (analisi e caratterizzazione) mediante spettrometria di massa di diverse formulazioni a base di lipidi e/o proteine lacrimali 49
CSF N-Glycoproteomics Using MALDI MS Techniques in Neurodegenerative Diseases 49
The Complete Structure and Pro-inflammatory Activity of the Lipooligosaccharide of the Highly Epidemic and Virulent Gram-Negative Bacterium Burkholderia cenocepacia ET-12 (Strain J2315) 47
Combined mass spectrometry methods for serum N-glycoprotein profiling enhance the awareness of the molecular patho-mechanism in ALG12-CDG 46
Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG) 44
ANALISI DEL GLICOMA DEL FLUIDO LACRIMALE IN PAZIENTI AFFETTI DA DISORDINI CONGENITI DELLA GLICOSILAZIONE (CDG) 43
Advanced LC-MS Methods for N-Glycan Characterization 43
Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis 42
DIFFERENCES IN DISEASE SEVERITY REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 41
Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA 41
Identificazione rapida di batteri mediante spettrometria di massa MALDI-TOF: dallo spettro del lipooligosaccaride all individuazione di batteri gram-negativi 40
Biophysical approaches to solve the structures of the complex glycan shield of chloroviruses 40
MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG 40
ALG12-CDG: novel glycophenotype insights endorse the molecular defect 37
Hyperkinetic movement disorders in congenital disorders of glycosylation 36
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 36
Sighting of unusual glycans 36
Minimal Heparin/Heparan Sulfate Sequences for Binding to Fibroblast Growth Factor-1 35
Tay-Sachs CSF N-Glycan Profile by MALDI MS Reveals Incomplete Glycosylation 35
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 35
Identification of N-Glycosylation in the CSF in Patients with Alzheimer's disease by MALDI Mass Spectrometry 34
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation 34
Tear Fluid N-Glycan Profiling To Investigate Biomarkers In Vernal Keratoconjunctivitis 33
Carbohidrate and Peptide Mapping di lactoferrine naturali e ricombinanti 33
Proteomic of human tear fluids in healthy and pathological conditions 32
Advances in purification methods of serum glycoproteins for MALDI_MS analysis of N-Glycome in patients with glycosylation disorders 31
Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation 31
Advances in purification methods of serum glycoproteins for MALDI-MS analysis of N- Glycome in CDG patients and in Galactosemia 31
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 31
DETERMINATION OF LINKAGE POSITIONS AND SEQUENCE OF COMPLEX CARBOHYDRATES BY MALDI-TOF-TOF MASS SPECTROMETRY 30
DIFFERENCES IN SEVERITY OF CLINICAL PHENOTYPE REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 30
Mass spectrometry strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 29
Glycomics of human serum: mass spectrometry investigations of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and glactosemia 29
Analisi mediante LC-MS di emulsioni per uso oftalmico 29
Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, self-assembly, and fluorimetry of recognition by Lens culinaris lectin 29
Cerebrospinal Fluid N-Glycomics May Enable Early Diagnosis in Alzheimer Disease 28
Trattamento di Prodotti Freschi Altamente Deperibili per Garantirne Qualità, Sicurezza e Salubrità (PROFSICURI) 28
Glycoproteomics of congenital disorders of glycosylation and secondary glycosylation disorders 28
Matrix-assisted Laser Desorption/Ionization Mass Spectrometry of Polysaccharides 28
Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides 28
Exopolysaccharides as bacterial defence tools: the case of Burkholderia cepacia Complex . 28
Analisi dei campioni di acido ialuronico coniugati con MTX 27
Full Structural Characterisation of the Lipooligosaccharide of a Burkholderia pyrrocinia Clinical Isolate 27
Maldi mass spectrometry for the structural investigation of intact lipopolysaccharides 27
Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype 26
Silver-Russel sindrome-like features in a patient with abnormal transferrin glycosylation 26
Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype) 26
Novel aspects of the contribution by the lipid A acyl groups to Toll-like receptor 4 activation by lipopolysaccharide 26
Differences in severity of clinical phenotype reflect diversity of glycosylation status in two sibs with phosphomannomutase deficiency (CDG-Ia) due to V129M/R141H mutations 25
Structural relationship of the lipid A acyl groups to activation of murine toll-like receptor 4 by lipopolysaccharides from pathogenic strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa 25
COG5-CDG with a Mild Neurohepatic Presentation 25
CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder 25
Thermophiles as potential source of novel endotoxin antagonists: The full structure and bioactivity of thelipo-oligosaccharide from thermomonas hydrothermalis 25
Mannosidase I deficiency: An unexpected CDG-II with intellectual disability and dysmorphic features 25
DEFICIENCY OF SUBUNIT 6 OF THE CONSERVED OLIGOMERIC GOLGI COMPLEX (COG6-CDG): SECOND PATIENT, DIFFERENT PHENOTYPE 25
Proprietà Strutturali di Polisaccaridi Prodotti dal Batterio Patogeno Opportunista Burkholderia cepacia 25
Detailed characterization of the lipid A fraction from the nonpathogen Acinetobacter radioresistens strain S13 25
Red blood cell N-glycan profiling by MALDI-MS 24
The structure of the exocellular polysaccharide from the cyanobacterium Cyanospira capsulata 24
The Outer Membrane of the Marine Gram-Negative Bacterium Alteromonas addita is Composed of a Very Short-Chain Lipopolysaccharide with a High Negative Charge Density 24
Preliminary results on proteomics of human tear fluids : Lack of bioactive peptides and defensins in disease subjects 24
HPLC ANALYSIS OF CYCLIC ADENOSINE-DIPHOSPHATE RIBOSE AND ADENOSINE-DIPHOSPHATE RIBOSE - DETERMINATION OF NAD(+) METABOLITES IN HIPPOCAMPAL MEMBRANES 24
Hypoglycosylation with increate fucosylation and branching of serum transferrin N-glycans in untreated galactosemia 23
Determination of the structure of the O-antigen and the lipid A from the entomopathogenic bacterium Pseudomonas entomophila lipopolysaccharide along with its immunological properties 23
Mass spectrometric strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 22
IDENTIFICATION OF N-ACETYLGLUCOSAMINE AND 4-O-[1-CARBOXYETHYL]MANNOSE IN THE EXOPOLYSACCHARIDE FROM CYANOSPIRA-CAPSULATA 22
Structural elucidation of the core-lipid A backbone from the lipopolysaccharide of Acinetobacter radioresistens S13, an organic solvent tolerant Gram-negative bacterium 21
Structural Analysis of the Deep Rough Lipopolysaccharide from Gram Negative Bacterium Alteromonas macleodii ATCC 27126T: The First Finding of B-Kdo in the Inner Core of Lipopolysaccharides 20
MAN2A2-related glycosylation defects in autism and cognitive delay 6
Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder 2
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation 1
Totale 3.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.870
article - articoli 7.043
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 925
Totale 19.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202433 0 0 0 0 0 0 0 0 3 3 21 6
2024/20251.724 0 2 102 54 417 52 141 111 93 104 342 306
2025/20262.018 104 167 230 286 395 81 326 92 100 133 104 0
Totale 3.775